Mark Iwicki Email
CEO . Inhibikase Therapeutics
How to contact Mark Iwicki
Join and see Mark's contact info for free!Current Roles
Employees:
8Revenue:
$804kAbout
Inhibikase Therapeutics (Nasdaq: IKT) is a clinical-stage pharmaceutical company focused on developing and commercializing small-molecule kinase inhibitor therapeutics that modify Parkinson's disease and drive functional reversal inside and outside of the brain. Inhibikase is headquartered in Atlanta, Georgia with additional offices in Boston, Massachusetts.Inhibikase Therapeutics Address
3350 Riverwood ParkwayATLANTA, GA
United States